Case report. Toepassing van 177Lu-PSMA bij een patiënt met gemetastaseerd castratieresistent prostaatcarcinoom

DSpace/Manakin Repository

Case report. Toepassing van 177Lu-PSMA bij een patiënt met gemetastaseerd castratieresistent prostaatcarcinoom
 
van Kalmthout, Ludwike W.M.; Braat, Arthur J.A.T.; Krijger, Gerard C.; Ververs, Tessa F.; de Roos, Remmert; de Keizer, Bart; Lam, Marnix G.E.H.
(2018) Tijdschrift voor Urologie, volume 8, issue Supplement 2, pp. 16 - 18
(Article)
Abstract
In December 2016, the first patient in the Netherlands was treated with lutetium-177 prostate specific membrane antigen (177Lu-PSMA); a promising application of radionuclide therapy in prostate carcinoma. This case report discusses the working mechanism of 177Lu-PSMA therapy. Furthermore, an overview of the published literature on this specific subject is presented.
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Lu-PSMA, lutetium-177 prostate specific membrane antigen, metastatic castration-resistant prostate carcinoma, Urology
DOI: https://doi.org/10.1007/s13629-018-0206-7
ISSN: 2211-3037
Publisher: Springer Science + Business Media
(Peer reviewed)